Oral Medicine, Oral Surgery and Implantology Unit, MedOralRes Group, University of Santiago de Compostela, Santiago, Spain.
ORALRES Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago, Spain.
J Oral Pathol Med. 2022 Jul;51(6):573-581. doi: 10.1111/jop.13317. Epub 2022 Jun 3.
Proliferative verrucous leukoplakia is considered an uncommon oral potentially malignant disorder with a high malignant transformation rate. The objective of this paper was to define its cancer incidence and related risk factors.
A retrospective audit of 34 patients diagnosed with proliferative verrucous leukoplakia from a university-based unit, during the period from 1995 to 2019 was performed. The mean number of visits was 23 ± 18.6. The follow-up was divided into four-time intervals to evaluate the clinical presentation, number of lesions, dysplasia grade, and malignant transformation rate.
The majority of patients were females 29 (85.3%), with verrucous component (77.8%), with a gingival presentation (31.8%), and with a preceding lichenoid area (44.1%). Eleven patients (32.4%) were affected by oral cancer during the follow-up, developing a total of 15 carcinomas. The mean age of malignant transformation was 67.2 ± 12.9 years, particularly 8 ± 8.5 from the onset of the lesions. Warty forms presented a higher mean estimate for malignant transformation (15.2 years, 95% confidence interval 4.4-26 years) than nodular forms (1.9 years, 95% confidence interval 1.9-1.9) (p = 0.019). Patients with an initial proliferative verrucous leukoplakia diagnosis suffered a higher risk of malignancy, particularly 15.55 times (95% confidence interval 1.69-143.17; p = 0.015) than those who did present a preceding area with lichenoid morphology.
Proliferative verrucous leukoplakia presented a high malignant transformation rate and sometimes displayed preceding oral lichenoid areas in early stages. Further studies are needed to understand the impact of these lichenoid areas in proliferative verrucous leukoplakia progression.
增殖性疣状白斑被认为是一种罕见的口腔潜在恶性疾病,具有较高的恶性转化率。本文旨在确定其癌症发病率及相关危险因素。
对 1995 年至 2019 年期间在一所大学附属医院诊断为增殖性疣状白斑的 34 例患者进行回顾性审核。平均就诊次数为 23 ± 18.6 次。随访分为四个时间段,以评估临床表型、病变数量、发育不良分级和恶性转化率。
大多数患者为女性 29 例(85.3%),疣状病变占 77.8%,病变位于牙龈者占 31.8%,且病变前有扁平苔藓样区域者占 44.1%。11 例(32.4%)患者在随访期间发生口腔癌,共发生 15 例癌。恶性转化的平均年龄为 67.2 ± 12.9 岁,尤其是从病变开始的 8 ± 8.5 岁。疣状形式的恶性转化平均估计值(15.2 年,95%置信区间 4.4-26 年)高于结节形式(1.9 年,95%置信区间 1.9-1.9)(p = 0.019)。最初诊断为增殖性疣状白斑的患者恶性转化风险更高,尤其是 15.55 倍(95%置信区间 1.69-143.17;p = 0.015)高于那些病变前有扁平苔藓样形态的患者。
增殖性疣状白斑具有较高的恶性转化率,有时在早期阶段会出现扁平苔藓样口腔病变。需要进一步研究以了解这些扁平苔藓样区域在增殖性疣状白斑进展中的影响。